Phi Therapeutics, Inc.

Amendment
CIK: 0001778492·Biotechnology·DELAWARE·Filed: Jun 26, 2024
Total Offering

$7,655,830

Amount Sold

$7,655,830

Investors

22

First Sale

Mar 22, 2023

Offering Details

Type
Equity, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
YUG VARMA
Related Person
JUN LI
Related Person
NEIL GIUGNO
Related Person
KEVIN LAW
Related Person

Company

Phi Therapeutics, Inc.

1250 PETALUMA BLVD N

PETALUMA, CA, 94952

707-243-8820

SEC Filing

0001778492-24-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Phi Therapeutics, Inc. Form D Filing — $7,655,830 | FilingFlow